With a robust background in healthcare investments, the fund manager has successfully executed over 25 deals across North America and Europe. Their strategic approach emphasizes operator-first methodologies, prioritizing partnerships with experienced management teams. Notable exits include several high-growth companies in the biotechnology and digital health sectors, showcasing a strong commitment to data-driven decision-making. This focus on early to growth-stage investments positions them well to capitalize on emerging trends in the healthcare landscape.